Main content

Generation of Nicotiana benthamiana with humanized N-glycosylation for therapeutic monoclonal antibody production

Show simple item record

dc.contributor.advisor Hall, J. Christopher
dc.contributor.author So, Kenny Kin Yang
dc.date.accessioned 2015-06-12T19:27:17Z
dc.date.available 2015-06-12T19:27:17Z
dc.date.copyright 2015-06
dc.date.created 2015-06-10
dc.date.issued 2015-06-12
dc.identifier.uri http://hdl.handle.net/10214/8918
dc.description.abstract To use plants for therapeutic monoclonal antibody (mAb) production, their N-glycosylation pathway must be humanized by precluding the attachment of the human-immunogenic sugars α1,3-fucose and β1,2-xylose, followed by the attachment of β1,4-galactose. A Nicotiana benthamiana line with humanized N-glycosylation was generated by transforming an α1,3-fucosylation and β1,2-xylosylation knockdown line (ΔFX) with the coding sequence (CDS) of a chimeric human β1,4-galactosyltransferase (hGalT) enzyme. The mAb trastuzumab, produced in this line, was galactosylated indicating this line to be suitable for therapeutic mAb production. Two new α1,3-fucosylation and β1,2-xylosylation deficient lines were also created. The first line, generated using RNA interference targeting the α1,3-fucosyltransferase and β1,2-xylosyltransferase genes, showed 55% knockdown of α1,3-fucosylation and β1,2-xylosation. The second line, achieved by transforming the chimeric hGalT CDS into wildtype N. benthamiana, showed knockdown of α1,3-fucosylation and β1,2-xylosylation comparable to the ΔFX line. These two knockdown lines can be used for producing non-galactosylated protein pharmaceuticals. en_US
dc.language.iso en en_US
dc.rights Attribution-NonCommercial-NoDerivs 2.5 Canada *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/2.5/ca/ *
dc.subject recombinant protein en_US
dc.subject N-glycosylation en_US
dc.subject monoclonal antibody en_US
dc.subject Agrobacterium-mediated transformation en_US
dc.subject trastuzumab en_US
dc.subject Nicotiana benthamiana en_US
dc.title Generation of Nicotiana benthamiana with humanized N-glycosylation for therapeutic monoclonal antibody production en_US
dc.type Thesis en_US
dc.degree.programme Environmental Sciences en_US
dc.degree.name Master of Science en_US
dc.degree.department School of Environmental Sciences en_US
dc.rights.license All items in the Atrium are protected by copyright with all rights reserved unless otherwise indicated.


Files in this item

Files Size Format View Description
So_Kenny_201506_MSc.pdf 2.338Mb PDF View/Open So_Kenny_201506_MSc

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 2.5 Canada Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 2.5 Canada